Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10.07. | Recalculation of warrants of series TO 8 in Smoltek Nanotech Holding AB | 1 | Cision News | ||
05.07. | Spotlight Stock Market: Market Notice 143/24 - Last day of trading in Smoltek Nanotech Holding AB's BTA | 1 | Cision News | ||
05.07. | SMOLTEK NANOTECH HOLDING AB: Smoltek announces the last day of trading in BTA | 1 | Cision News | ||
02.07. | SMOLTEK NANOTECH HOLDING AB: Smoltek has been granted a new patent that improves the capacitance density of the company's CNF-MIM capacitors | 1 | Cision News | ||
27.06. | SMOLTEK NANOTECH HOLDING AB: The board of Smoltek has decided on a directed issue of shares to the underwriters in the completed rights issue | 1 | Cision News | ||
19.06. | Spotlight Stock Market: Market Notice 128/24 Information regarding Smoltek Nanotech Holding AB's subscribed share | 1 | Cision News | ||
19.06. | SMOLTEK NANOTECH HOLDING AB: Smoltek has the technology for next-generation capacitors and is seeking financially strong partners to industrialize it | 1 | Cision News | ||
19.06. | SMOLTEK NANOTECH HOLDING AB: Smoltek's rights issue was subscribed to 86.4 percent without the use of underwriting commitments and the company receives SEK 22.4 million | 1 | Cision News | ||
18.06. | SMOLTEK NANOTECH HOLDING AB: Smoltek announces preliminary outcome in rights issue which indicates that the minimum level is reached | 3 | Cision News | ||
14.06. | Smoltek: We have technology to make green hydrogen production profitable | 4 | Offshore Energy Today | ||
13.06. | SMOLTEK NANOTECH HOLDING AB: Smoltek has the future technology for the capacitor industry | 1 | Cision News | ||
13.06. | SMOLTEK NANOTECH HOLDING AB: Smoltek publishes answers to questions from the company's community regarding the ongoing new issue and bidding process | 1 | Cision News | ||
13.06. | SMOLTEK NANOTECH HOLDING AB: Smoltek has the technology to make production of green hydrogen profitable and is seeking financially strong partners to scale up manufacturing of its nanomaterial | - | Cision News | ||
11.06. | SMOLTEK NANOTECH HOLDING AB: Last day for trading in subscription rights in Smoltek's rights issue of shares | 1 | Cision News | ||
31.05. | SMOLTEK NANOTECH HOLDING AB: The subscription period in Smoltek's rights issue of shares starts today | 3 | Cision News | ||
30.05. | SMOLTEK NANOTECH HOLDING AB: Smoltek publishes information memorandum in connection with rights issue of shares | 1 | Cision News | ||
30.05. | XFRA CAPITAL ADJUSTMENT INFORMATION - 30.05.2024 | 994 | Xetra Newsboard | Das Instrument IWY1 US82655M1071 SIFY TECHNO.LTD.ADR IR 10 EQUITY wird cum Kapitalmassnahme gehandelt am 30.05.2024 und ex Kapitalmassnahme am 31.05.2024 The instrument IWY1 US82655M1071 SIFY TECHNO.LTD.ADR... ► Artikel lesen | |
24.05. | SMOLTEK NANOTECH HOLDING AB: A world-leading vehicle manufacturer is testing custom-made cell material from Smoltek | 2 | Cision News | ||
24.05. | Spotlight Stock Market: Market Notice 97/24 - Information regarding the rights issue from Smoltek Nanotech Holding AB | 2 | Cision News | ||
23.05. | SMOLTEK NANOTECH HOLDING AB: Smoltek holds a webinar about the company's future direction | 2 | Cision News |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 51,90 | +5,06 % | EQS-Adhoc: Formycon AG: Stelara® Biosimilar-Kandidat FYB202 (Ustekinumab) erhält CHMP-Empfehlung der EMA | EQS-Ad-hoc: Formycon AG / Schlagwort(e): Stellungnahme/Zulassungsantrag
Stelara® Biosimilar-Kandidat FYB202 (Ustekinumab) erhält CHMP-Empfehlung der EMA
26.07.2024 / 10:54 CET/CEST
Veröffentlichung... ► Artikel lesen | |
GAUZY | 10,380 | +8,01 % | Gauzy Ltd. Announces Preliminary Revenue Ranges, Demonstrating Strong Double-Digit Growth for the Second Quarter and First Half 2024 that Exceeded Expectations | TEL AVIV, Israel, July 15, 2024 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control solutions, today provided preliminary unaudited... ► Artikel lesen | |
ACACIA RESEARCH | 5,250 | +7,14 % | Acacia Research Reports First Quarter 2024 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company") today reported financial results for the three months ended March 31, 2024.
Martin ("MJ") D.... ► Artikel lesen | |
NVE | 77,00 | -1,91 % | Dividendenbekanntmachungen (10.05.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAK AB SE0011337708 3,7 SEK 0,3163 EUR ADDLIFE AB SE0014401378 0,5 SEK 0,0427 EUR ALEXANDERS INC US0147521092 4,5 USD 4,1738... ► Artikel lesen | |
KOPIN | 1,009 | +1,92 % | Kopin Corporation: Kopin Expands Medical Offerings to Include Spatial Light Modulator That Enable Super-Resolution Microscopes | Ferroelectric LCOS modulators advance open-source research at top Medical, Biomedical and Research Institutions
Kopin Corporation (NASDAQ: KOPN), a leader in cutting-edge high-performance application-specific... ► Artikel lesen | |
FENDX TECHNOLOGIES | 0,158 | -2,48 % | FendX Technologies Inc.: FendX Completes Successful Pilot Scale-Up Run of REPELWRAP Film with Dunmore | Oakville, Ontario--(Newsfile Corp. - July 24, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX") a nanotechnology company developing surface protection... ► Artikel lesen | |
VEECO INSTRUMENTS | 36,000 | -1,10 % | Veeco Instruments Inc.: Veeco Reports Fourth Quarter and Fiscal Year 2023 Financial Results | Fourth Quarter 2023 Highlights: Revenue of $173.9 million, compared with $153.8 million in the same period last yearGAAP net income of $21.6 million, or $0.37 per diluted share, compared with $128.9... ► Artikel lesen | |
XTPL | 24,350 | -5,07 % | EQS-News: XTPL S.A.: XTPL achieves PLN 5.5 million of commercial sales in H1 2024, two industrial modules delivered to clients | Issuer: XTPL S.A.
/ Key word(s): Preliminary Results/Sales Result
XTPL achieves PLN 5.5 million of commercial sales in H1 2024, two industrial modules delivered to clients
18.07.2024... ► Artikel lesen | |
ONTO INNOVATION | 177,00 | +1,72 % | (ONTO) - Analyzing Onto Innovation's Short Interest | ||
ADVANCE ZINCTEK | 0,432 | -1,82 % | ADVANCE ZINCTEK LIMITED: FY24 Loss Before Tax | ||
NANOFOCUS | 1,250 | 0,00 % | EQS-Adhoc: NanoFocus AG: Ergänzungsverlangen zur Tagesordnung der ordentlichen Hauptversammlung am 28. August 2024 | EQS-Ad-hoc: NanoFocus AG / Schlagwort(e): Hauptversammlung
NanoFocus AG: Ergänzungsverlangen zur Tagesordnung der ordentlichen Hauptversammlung am 28. August 2024
25.07.2024 / 19:27 CET/CEST
Veröffentlichung... ► Artikel lesen | |
NANOVIRICIDES | 2,080 | +0,97 % | COVID is Here to Stay and NV-387 is a Much Needed Drug Against It, Reminds NanoViricides | SHELTON, CT / ACCESSWIRE / July 24, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today reminds the strong... ► Artikel lesen | |
LEHNER INVESTMENTS | 0,013 | 0,00 % | EQS-DD: LEHNER INVESTMENTS AG: RIMIVY LTD, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
05.07.2024 / 16:36... ► Artikel lesen | |
RIBER | 2,470 | 0,00 % | Riber's first-half revenue up 13% year-on-year to €13.7m | ||
ZENTEK | 0,875 | -6,42 % | Zentek Launches National Sampling Program for ZenGUARD Antimicrobial Surgical Masks | GUELPH, ON / ACCESSWIRE / July 24, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it will embark... ► Artikel lesen |